Business Blockbuster - Helpng business to be more visible on Google

Daily Bulletin

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

  • Written by: PR Newswire Asia - Daily Bulletin Au RSS

CAMBRIDGE, England and SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated by its "First in Human" Coronavirus vaccine trial, to announce its new portfolio of pre-pandemic Bird-Flu, supra-Seasonal and Universal-type Influenza vaccines, alongside the unveiling of its new advisory board.

The Company's Bird Flu vaccine has now demonstrated efficacy and safety in animal models including Ferrets and is ready for human trials. The unique vaccine is designed to trigger robust, broadly protective immune responses against a range of high consequence viruses such as those that can arise from globally occurring human Bird-Flu cases that threaten public and global health. As the number of Bird-Flu infections rise world-wide and the first reported death due to the virus has now occurred in the US (https://www.washingtonpost.com/health/2025/01/06/bird-flu-first-human-death-us/, countries worldwide are preparing for a potential Bird-Flu outbreak in humans – (The New York Times). The company's "Digital Immune Optimized Synthetic Vaccine" (DIOSynVax) technology is strategically positioned to leverage AI to rapidly advance safer, stronger vaccines for today, smarter for tomorrow threats.

During the COVID-19 pandemic DIOSynVax pivoted to use it computational technology to develop a broadly protective vaccine against SARS, SARS-CoV-2 and related coronaviruses. Following extensive evaluation for safety and efficacy in animals (Vishwanath et al, Nature Biomedical Engineering 2023), the "First-in-Human" Phase 1 clinical trial of this revolutionary digitally engineered vaccine antigen was conducted at the NIHR Southampton and Cambridge Clinical Research Facilities and enrolled healthy volunteers. The vaccine was administered using a needle-free device into the skin and the results revealed that the vaccine was safe and well tolerated.

Dr. Rebecca Kinsley, Chief Operating Officer of DIOSynVax, commented on the significance of the trial results: "While we are now focusing on our influenza vaccines, this trial has confirmed the strong safety profile of our "Digital-Immune-Optimised Synthetic" antigen and ability to induce broad immune responses. This is a critical step forward as we move towards developing vaccines for supra-Seasonal influenza, pre-pandemic Bird--Flu, and ultimately a Universal-type influenza vaccine."

Professor Jonathan Heeney, Chief Scientific Officer of DIOSynVax, added: "The results of this clinical study using our technology lay the foundation for our influenza vaccine development. The technology offers several advantages, including improved safety, fewer required immunizations, and the ability to anticipate new viral strains as they emerge. We are excited to advance our mRNA-based influenza candidates and expedite proof of concept in the coming months."

In addition to the clinical trial announcement, DIOSynVax also revealed the formation of a new advisory board, composed of leading experts from the pharmaceutical and academic sectors. This board will provide critical insights as the company advances its influenza vaccine candidates toward clinical trials and commercialization.

Dr. Ronald Moss, CEO of DIOSynVax, remarked: "We are excited to have such a distinguished advisory board to guide our efforts as we bring our vaccines to the clinic and form strategic partnerships. Our innovative approach holds significant promise both from a public health perspective and a commercial standpoint, and we are committed to accelerating its development as a vital countermeasure against future pandemics. Notably, our Bird-flu vaccine has several advantages to others and should be utilized to de-risk the current pandemic threat".

For more information about DIOSynVax, including details about the new advisory board, please visit https://www.diosynvax.com/advisoryboard. 

About DIOSynVaxDIOSynVax is a clinical-stage biotechnology company focused on developing universal vaccines using cutting-edge artificial intelligence technologies. The company's mission is to provide broad protection against a wide range of infectious diseases, with a particular focus on emerging viral threats that may lead to future pandemics.

For further information, please connect with us at JP Morgan,  Ron Moss, CEO.  Email: ron.moss@diosynvax.com  

or contact:Email: contact@diosynvax.com Website: Advisory Board | DIOSynVax

About COVID-19For more information about COVID-19, visit the CDC website.

About H5N1 (Bird Flu)H5N1, or bird flu, continues to pose a significant threat to public health, particularly if the virus undergoes mutations that enable transmission among humans. For further details, visit the CDC H5N1 situation summary.

 

Authors: PR Newswire Asia - Daily Bulletin Au RSS

Read more https://www.prnasia.com/story/archive/4591869_AE91869_0

Business News

The Growing Demand for Durable Plastic Packaging Supplies Across Australia

Why Do Australian Businesses Need Reliable Plastic Packaging Supplies? Businesses need packaging that can withstand everyday handling, storage, and distribution without creating avoidable delays. Pla...

Daily Bulletin - avatar Daily Bulletin

Office Cleaning Melbourne: Choosing the Right Scope for Your Office

A well-planned office cleaning Melbourne arrangement starts with a clear understanding of the premises and the people who use it. An office may include private work areas, shared desks, reception, mee...

Daily Bulletin - avatar Daily Bulletin

How Businesses Can Prepare for Unexpected Power Outages

Power failures can occur quickly. The supply may be interrupted by bad weather, issues with the electricity network, damaged equipment or local construction work. This can be just a hassle for a fam...

Daily Bulletin - avatar Daily Bulletin

How Chatswood Tutoring Can Fit Into a Student’s Weekly Routine

Create a Predictable Weekly Structure A consistent weekly routine can make study easier to manage when students are balancing several subjects. Chatswood tutoring can provide a fixed learning point a...

Daily Bulletin - avatar Daily Bulletin

The Rise of Digital Marketplaces in the Australian Trade Sector

For decades, the Australian trade and construction sector operated almost entirely on word-of-mouth recommendations and local community networks. Small business owners typically relied on local newspa...

Daily Bulletin - avatar Daily Bulletin

How Immigration Lawyers Can Help

Introduction Visa decisions can shape employment, family life, study plans, travel, and future residence. A small omission can lead to delay, added expense, or refusal. Immigration lawyers assess l...

Daily Bulletin - avatar Daily Bulletin

How Industrial Drying Equipment Supports Efficient Processing

Many industrial processes require moisture to be removed from compressed air, products or process materials before they move to the next stage. Excess moisture can affect equipment performance, produc...

Daily Bulletin - avatar Daily Bulletin

Practical Ways a Whiteboard Can Improve Workplace Communication

Effective communication helps teams stay organised, share ideas and keep track of important information. While digital tools are now common in many workplaces, a whiteboard continues to provide a simp...

Daily Bulletin - avatar Daily Bulletin

Designing Eco-Friendly Custom Water Bottles for Your Next Event

The Evolution of Sustainable Event Merchandise Event planning has undergone a massive transformation over the last decade. Gone are the days when organizers could hand out cheap, single use plastic...

Daily Bulletin - avatar Daily Bulletin

The Daily Magazine

Work Boots vs Safety Shoes: Which Footwear Is Right for Your Workplace?

Not every job calls for a heavy pair of boots. Walk through a modern warehouse, factory floor or dis...

Master Bedroom Wall Decor Guide: Sizing, Layouts and Styling Ideas for Every Space

The main bedroom is often the last room in the house to get any attention. The living room gets the ...

What to Consider Before Installing a Built-In Wardrobe

Living in a modest home teaches you a lot. You learn how to keep a small kitchen tidy, where to hi...

Top 5 Mortgage Brokers in Sydney: How to Choose the Right One in 2027

Finding a mortgage broker in Sydney is not particularly difficult. Finding one who understands your ...

How Much Life Does Your Roof Have Left? Recognizing When Replacement Becomes Necessary

A roof can age quietly for years. From the street, everything may look reassuringly ordinary, even w...

How Australian Drivers Can Make Their Cars Harder to Steal

Most people don't think much about car theft until it happens to them, or to someone they know. Th...

The Short-Term Rental Rules Australian Owners Can’t Afford to Guess At

A holiday let looks simple from the outside: a spare property, a listing, some guests. Underneath ...

The Risks Of Removing Ear Wax Without Professional Guidance

Ear wax is an essential component of the hygiene process since it acts as a barrier between the ea...

Plumbing Call-Out Fees in Perth Explained

When you hire a plumber to fix a problem with a dripping tap, leaking pipe, or whatever it might be...